Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
China
Enrollment target
~60 participants
Started
April 2026
Primary completion
March 2028
Age range
18 Years – 70 Years
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
jianbo Li
The First Affiliated Hospital with Nanjing Medical University